Clear the path to market with faster approvals, smarter execution, and built-in regulatory foresight.
Market Entry Acceleration Program helps brands understand market dynamics, navigate evolving regulatory guidelines, and build tailored regulatory strategies - enabling confident, compliant, and well-informed product launches across complex and competitive environments.
Structured Journey to
ComplianceBuilt to guide every step with clarity, speed, and regulatory precision - from planning to execution.
In-depth review of formulation, ingredient acceptability, and dossier availability to evaluate regulatory readiness.
Strategic analysis to identify accessible markets for the product based on category fit, regulatory pathways, and compliance barriers.
Identification of optimal submission pathways based on product type and target market.
Detailed checklist of regulatory documents, technical files, and data required and gap analysis per region and product classification.
Market-by-market estimation of approval timelines and milestone planning to align internal launch schedules and supply readiness.
For digitally regulated markets (e.g., US, EU, GCC)
For ASEAN markets following harmonized technical standards
For regions accepting non-eCTD digital structures
For markets with unique formats, administrative structures, or local language needs
Preparation and filing of product-specific regulatory applications
End-to-end management of Drug Master Files and Chemistry, Manufacturing & Controls sections
Handling of regulatory queries, clarification requests, and pre/post-submission communication
Acting as the local MAH in eligible markets to enable compliant registration
Leveraging trusted local partners to hold MAH with oversight from Regnova
Serving as the official local representative for regulatory interactions
Analyse target market trends, applicable regulatory classifications, and category-specific challenges.
Evaluate ingredient acceptability, restrictions, and pre-approval status based on regional regulations.
Assess chemical, functional, and regulatory compatibility between components in the intended formulation.
Conduct trials to determine stability, solubility, and potential interactions of selected ingredients.
Establish the complete technical formulation, listing all components with defined specifications.
Prepare small-scale batches to validate formulation performance and process parameters.
Assess key properties such as pH, viscosity, dispersion, and appearance for initial quality benchmarks.
Execute limited-scale production runs to simulate commercial manufacturing conditions and process scalability.
Conduct validated analytical testing and ICH-compliant stability studies to establish product shelf life.
Evaluate the safety and performance profile through clinical data review or documented claims substantiation.
Ensure formulation and process compatibility with identified CDMOs or manufacturing partners.
Assess packaging formats for compatibility, stability, regulatory compliance, and cost efficiency.
Establish automated or manual workflows for capturing and reporting adverse events as per global requirements.
Analyse cumulative safety data to identify new risks and assess evolving product benefit-risk profiles.
Process AE reports, evaluate causality, and submit cases to relevant health authorities using approved formats.
Create compliant, product-specific procedures for logging, reviewing, and closing complaints.
Deploy digital or manual systems to capture complaints and trigger structured investigations.
Apply structured problem-solving tools to uncover systemic or recurring product issues.
Monitor and report on complaint patterns to detect early warning signs and improve product performance.
Prepare summaries of safety data and regulatory actions for ongoing benefit-risk assessment.
Generate Post-Market Clinical Follow-up reports to demonstrate continued device safety and effectiveness.
Analyse adverse event or complaint trends to meet EU MDR surveillance requirements.
Compile jurisdiction-specific reports as required for ongoing local market approvals.
Services
Get regulatory-aligned manufacturing support with vetted CMOs for scalable, compliant product supply
Facilitate strategic discussions with Health Authorities to clarify pathways and accelerate approvals.
Access early insights on market dynamics, competitor positioning, and regulatory barriers before launch.
USP
Flexibility
Structured Execution Model
Structured Execution Model
Our Global
PresenceProven Impact.
Precision in ExecutionAccelerated product approvals, reduced submission cycles, and multi-market access - delivered through structured execution and regulatory foresight.
From compliance to commercial success we’ve got you covered.
Questions
Yes - the program is fully modular. You can choose specific steps based on your internal readiness and regulatory needs.
Timelines vary by product type and market, but most projects are completed within 6-9 months, which is 15-20% faster than standard industry timelines.
It’s built for both. Whether you're entering a market for the first time or expanding your footprint, the program adapts to your regulatory maturity and market goals.
Regnova or its channel partners can act as MAH or legal representatives, ensuring full compliance without needing a local entity.
Unlike traditional advisory models, this program offers end-to-end execution -from feasibility assessment to dossier submission and MAH support -with built-in speed and regional alignment.
Break into new markets with speed, certainty, and structure -through a program built for real-world approvals and expansion.